About the Summit

Are We Ready to End Alzheimer's?

This theme will set the stage for examining the progress made over the last year, including FDA approval of the first disease-slowing therapy, and the challenges still ahead to addressing our nation’s shared crisis, while embedding UsA2’s cross cutting priorities, including:

  • Promoting Early Intervention and Brain Health
  • Accelerating Treatments and Research
  • Advancing Health Equity and Access
  • Amplifying the Voices of Alzheimer's

2021 Summit Themes

Promoting Early Intervention and Brain Health

Focusing on strategies for developing proactive brain health across the life span by mobilizing communities, consumers, providers and policymakers to transform the healthcare system.

Advancing Health Equity and Access

Accelerating equitable access to innovations in brain health for communities of color and women who have faced systemic discrimination and racism when accessing healthcare services and research.

Accelerating Treatments and Research

Highlighting innovations across the Alzheimer’s research community, including patient- and caregiver-centered engagement and drug development.

Amplifying the Voice of People Living with the Disease

Identifying what matters most to people living with the Alzheimer’s and exploring how these needs and preferences can be prioritized in research, policymaking and drug development.

October 13–14, 2021

UsAgainstAlzheimer’s (UsA2) will host four town halls over two days that bring together partners and advocates from across the country for conversations on the multidimensional impacts of Alzheimer’s on society. The town halls will center on key issues such as the effects of systemic racism on the efforts to promote health equity and access, how COVID-19 has affected the dementia community, the path forward to new therapies and treatments, and the critical importance of risk reduction and prevention as well as treatment. These conversations will drive toward solutions for a healthier and more equitable future.